MINOIA, Mariella
 Distribuzione geografica
Continente #
NA - Nord America 2.891
AS - Asia 1.497
EU - Europa 834
SA - Sud America 243
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 2
Totale 5.522
Nazione #
US - Stati Uniti d'America 2.837
SG - Singapore 551
CN - Cina 399
DE - Germania 202
VN - Vietnam 202
BR - Brasile 183
UA - Ucraina 134
HK - Hong Kong 104
FI - Finlandia 100
GB - Regno Unito 100
TR - Turchia 89
IT - Italia 82
FR - Francia 60
RU - Federazione Russa 42
SE - Svezia 41
JP - Giappone 33
IN - India 29
CA - Canada 26
BD - Bangladesh 25
AR - Argentina 21
MX - Messico 18
AT - Austria 13
ZA - Sudafrica 13
IQ - Iraq 11
PL - Polonia 10
EC - Ecuador 9
ES - Italia 9
ID - Indonesia 9
LT - Lituania 9
CO - Colombia 8
NL - Olanda 8
PK - Pakistan 8
VE - Venezuela 8
BE - Belgio 6
UZ - Uzbekistan 6
CL - Cile 5
AL - Albania 4
EG - Egitto 4
LB - Libano 4
PY - Paraguay 4
DZ - Algeria 3
JO - Giordania 3
UY - Uruguay 3
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 5.497
Città #
Singapore 396
Ashburn 379
Woodbridge 246
San Jose 219
Chandler 184
Fairfield 178
Houston 175
Jacksonville 148
Santa Clara 129
Beijing 116
Hong Kong 102
Wilmington 82
Ann Arbor 81
Ho Chi Minh City 74
Seattle 74
Munich 66
Cambridge 64
Los Angeles 53
Addison 47
Izmir 42
New York 41
Hanoi 39
Helsinki 38
Nanjing 37
Tokyo 33
Turku 33
Dallas 32
Princeton 30
Shanghai 30
Dearborn 27
Lauterbourg 27
São Paulo 26
Boardman 25
Bremen 23
Milan 21
Ferrara 20
Orem 19
Buffalo 17
Shenyang 16
London 15
Nuremberg 14
Brooklyn 13
Chennai 13
Denver 13
Jinan 13
Nanchang 13
Changsha 12
Mexico City 12
San Diego 12
Tianjin 11
Atlanta 10
Da Nang 10
Johannesburg 10
Warsaw 10
Chicago 8
Falls Church 8
Poplar 8
Frankfurt am Main 7
Haiphong 7
Hebei 7
Montreal 7
Mountain View 7
Stockholm 7
Amsterdam 6
Ankara 6
Boston 6
Brussels 6
Indiana 6
Manchester 6
Moscow 6
Toronto 6
Washington 6
Auburn Hills 5
Belo Horizonte 5
Caracas 5
Council Bluffs 5
Guangzhou 5
Hải Dương 5
Jiaxing 5
Kunming 5
New Delhi 5
Norwalk 5
Orange 5
Piscataway 5
Baghdad 4
Barnet 4
Hefei 4
Jakarta 4
Medellín 4
Miami 4
Ningbo 4
Osasco 4
Paris 4
Phoenix 4
Quito 4
Rome 4
San Francisco 4
Secaucus 4
Tappahannock 4
Tashkent 4
Totale 3.814
Nome #
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 289
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 254
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 250
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 234
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 219
Growth hormone excess promotes breast cancer chemoresistance 216
Growth hormone induces chemoresistance in breast cancer cells 216
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 216
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 213
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 207
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 197
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 191
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 188
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 186
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 182
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 181
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 180
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 177
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 174
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 173
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 166
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 164
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 154
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 152
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 149
mTOR inhibitors hamper cell viability in selected human medullary thyroid carcinoma primary cultures 145
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 143
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 113
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  109
null 44
null 40
Totale 5.522
Categoria #
all - tutte 23.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.669


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022288 7 35 13 2 8 18 14 6 6 29 41 109
2022/2023387 33 41 18 55 64 52 20 26 48 4 12 14
2023/2024209 15 16 8 6 18 37 8 53 5 2 2 39
2024/2025797 16 9 50 18 100 120 17 17 111 82 115 142
2025/20262.148 209 109 167 260 385 139 282 101 209 194 75 18
2026/202734 34 0 0 0 0 0 0 0 0 0 0 0
Totale 5.522